ÌÇÐÄvlog

[Skip to Navigation]
Sign In

October 2024 - July 1959

Decade

Year

Issue

December 2023, Vol 80, No. 12, Pages 1180-1287

Viewpoint

Mental Health in a Changing Planet

Abstract Full Text
JAMA Psychiatry. 2023;80(12):1181-1182. doi:10.1001/jamapsychiatry.2023.3410

This Viewpoint discusses climate change and its effect on mental health.

Climate Change and Mental Health—Time to Act Now

Abstract Full Text
JAMA Psychiatry. 2023;80(12):1183-1184. doi:10.1001/jamapsychiatry.2023.3413

This Viewpoint discusses the lack of research on the impact of climate events on mental health, climate change–related inequalities in low- and middle-income countries, and the immediate need to act now.

Perinatal Mental Health Outcomes Following Natural Disasters

Abstract Full Text
JAMA Psychiatry. 2023;80(12):1185-1186. doi:10.1001/jamapsychiatry.2023.3564

This Viewpoint discusses mental health outcomes associated with natural disaster–related stressors during the perinatal period.

Choosing Between Ketamine and Electroconvulsive Therapy for Outpatients With Treatment-Resistant Depression—Advantage Ketamine?

Abstract Full Text
JAMA Psychiatry. 2023;80(12):1187-1188. doi:10.1001/jamapsychiatry.2023.3979

This Viewpoint examines key issues stemming from several recent reports of electroconvulsive therapy (ECT) vs ketamine for improving depressive symptoms in treatment-resistant depression (TRD).

Ketamine for Depression—Knowns, Unknowns, Possibilities, Barriers, and Opportunities

Abstract Full Text
JAMA Psychiatry. 2023;80(12):1189-1190. doi:10.1001/jamapsychiatry.2023.3982

This Viewpoint discusses ketamine and its new and experimentally investigated on- and off-label indications that span different medical disciplines.

Editorial

Maternal Depression, Prenatal SSRI Exposure, and Brain Trajectories in Childhood

Abstract Full Text
JAMA Psychiatry. 2023;80(12):1191-1192. doi:10.1001/jamapsychiatry.2023.2664

Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency

Abstract Full Text
free access
JAMA Psychiatry. 2023;80(12):1193-1195. doi:10.1001/jamapsychiatry.2023.4679
Original Investigation

Efficacy and Safety of Antidepressants in Patients With Comorbid Depression and Medical Diseases: An Umbrella Systematic Review and Meta-Analysis

Abstract Full Text
free access
JAMA Psychiatry. 2023;80(12):1196-1207. doi:10.1001/jamapsychiatry.2023.2983

This systematic review and meta-analysis assesses all available evidence for use of antidepressants in depression comorbid with medical diseases.

Prenatal Antidepressant Exposure and Offspring Brain Morphologic Trajectory

Abstract Full Text
free access
JAMA Psychiatry. 2023;80(12):1208-1217. doi:10.1001/jamapsychiatry.2023.3161

This cohort study examines whether intrauterine exposure to selective serotonin reuptake inhibitors and prenatal or postnatal depressive symptoms are associated with brain morphologic trajectory in offspring.

Determinants and Outcomes of Suicidal Behavior Among Patients With Major Depressive Disorder

Abstract Full Text
open access
JAMA Psychiatry. 2023;80(12):1218-1225. doi:10.1001/jamapsychiatry.2023.2833

This cohort study examines the outcomes and associated risk factors of suicidal behavior in patients with major depressive disorder.

Association of Childhood Area-Level Ethnic Density and Psychosis Risk Among Ethnoracial Minoritized Individuals in the US

Abstract Full Text
free access
JAMA Psychiatry. 2023;80(12):1226-1234. doi:10.1001/jamapsychiatry.2023.2841

This cohort study examines the association between area-level ethnic density during childhood, perceived discrimination, and psychosis risk outcomes among ethnoracial minoritized individuals at clinical high risk for psychosis.

Diagnostic Specificity and Association With Cognition of Molecular Alterations in Prefrontal Somatostatin Neurons in Schizophrenia

Abstract Full Text
free access
JAMA Psychiatry. 2023;80(12):1235-1245. doi:10.1001/jamapsychiatry.2023.2972

This case-control study examines mRNA levels of somatostatin (SST) in the dorsolateral prefrontal cortex of postmortem brain specimens from patients with schizophrenia, bipolar disorder, and major depression disorder to assess whether alterations in SST levels are diagnosis specific and associated with cognitive dysfunction.

Network-Based Spreading of Gray Matter Changes Across Different Stages of Psychosis

Abstract Full Text
free access
JAMA Psychiatry. 2023;80(12):1246-1257. doi:10.1001/jamapsychiatry.2023.3293

This case-control study models the processes that explain spatial patterns of gray matter volume loss in different stages of psychotic illness and assesses whether certain brain regions act as putative epicenters from which volume loss spreads.

Social Deprivation and Population Density Trajectories Before and After Psychotic Disorder Diagnosis

Abstract Full Text
free access
JAMA Psychiatry. 2023;80(12):1258-1268. doi:10.1001/jamapsychiatry.2023.3220

This case-control study examines whether patients diagnosed with psychotic disorder or nonpsychotic bipolar disorder differed from a control group in their deprivation and population density trajectories.

Gabapentin Use Among Individuals Initiating Buprenorphine Treatment for Opioid Use Disorder

Abstract Full Text
free access
JAMA Psychiatry. 2023;80(12):1269-1276. doi:10.1001/jamapsychiatry.2023.3145

This case-control study with crossover analysis assesses the differences between patients receiving and not receiving gabapentin alongside buprenorphine in the treatment of opioid use disorder and the drug-related poisoning risk associated with gabapentin.

One-Year Association of Drug Possession Law Change With Fatal Drug Overdose in Oregon and Washington

Abstract Full Text
free access
JAMA Psychiatry. 2023;80(12):1277-1283. doi:10.1001/jamapsychiatry.2023.3416

This cohort study examines the rates of fatal drug overdose in Oregon and Washington 1 year after implementation of policy changes eliminating or lower criminal charges for drug possession.

Brief Report

Prevalence of Autism Among Medicaid-Enrolled Adults

Abstract Full Text
JAMA Psychiatry. 2023;80(12):1284-1287. doi:10.1001/jamapsychiatry.2023.3708

This cohort study uses Medicaid claims data to estimate the prevalence of autistic adult enrollees.

JAMA Psychiatry Masthead

JAMA Psychiatry

Abstract Full Text
free access
JAMA Psychiatry. 2023;80(12):1180. doi:10.1001/jamapsychiatry.2022.3248
×